to be greater than 0.60 to 1.00 or, if
requested by the Company, 0.65 to 1.00 for the four quarters following an
acquisition in which total cash consideration is equal to or greater than $1.0
billion.. | April 28, 2023
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
On April 26, 2023, the Board of Directors adopted and approved
Amended and Restated Bylaws of Apartment. | April 28, 2023
ITEM 2.02 - RESULTS OF OPERATION AND FINANCIAL CONDITION
On April 28, 2023, ImmunoGen, Inc. issued a press release to
announce the Company s financial results for the quarter ended March 31,. | April 28, 2023